Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2026-02-24 @ 10:05 AM
Study NCT ID:
NCT02031120
Status:
TERMINATED
Last Update Posted:
2025-03-19
First Post:
2014-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Management of Drug Hypersensitivity in Children
Sponsor:
University Hospital, Geneva
Organization:
Study Overview
Official Title:
Improved Management Based on Pathophysiology of Drug Hypersensitivity in Childhood
Status:
TERMINATED
Status Verified Date:
2025-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Difficulty recruiting participants.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DHC
Brief Summary:
The aim of this study is (1) to assess the incidence of suspected drug allergies in a pediatric hospital and the proportion in which these reactions are confirmed to be allergic; (2) to evaluate the diagnostic values of the different allergy tests available; (3) to investigate the pathophysiology of drug allergies, particularly by investigating the role of viruses, and by performing HLA typing and a gene expression profile both in the acute phase of the reaction and 2 months later.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: